Inside the First Weeks of Childhood Leukemia: What Parents Say They Need Most

When a child is diagnosed with acute lymphoblastic leukemia, the most common childhood cancer, the weeks that follow are among the most disorienting a family will ever face. The induction phase, the first and most intensive stage of treatment, requires prolonged hospitalization, aggressive chemotherapy, and a rapid crash course in medical vocabulary that no parent ever asked to learn. A new qualitative study published in the Journal of Child and Family Studies offers one of the most detailed portraits yet of what families actually go through during this critical window, drawing on the voices of forty-one Portuguese parents whose children were being treated at three major cancer hospitals in Portugal. The findings, researchers say, carry a clear message for clinicians: support for families cannot wait until the treatment plan is underway, because the crisis begins the moment the diagnosis is delivered.

The research team, led by Ana Ferraz, Martim Santos, Mónica Jerónimo, and M. Graça Pereira of the University of Minho and the Pediatric Hospital of Coimbra, asked parents to answer eleven open-ended survey questions about their own experiences and those of their children during hospitalization. Rather than testing a hypothesis with numbers, the team used inductive content analysis, a qualitative method in which themes are allowed to emerge from the data itself rather than being imposed in advance. The responses were coded and organized with NVivo software, a standard tool for managing large volumes of textual data. From this analysis, five key themes surfaced, and together they map the emotional and practical terrain families must cross from diagnosis through the end of induction.

The first theme, being confronted with the illness trajectory, captures the shock of diagnosis and the steep learning curve that follows. Parents described the moment they learned their child had cancer as a rupture in the ordinary flow of family life, followed immediately by an avalanche of information about protocols, risks, and procedures. Acute lymphoblastic leukemia is, by the standards of pediatric oncology, a success story: survival rates in high-income countries now exceed ninety percent thanks to decades of coordinated clinical trials. But the researchers emphasize that statistical reassurance does little to soften the initial blow, because parents in the induction phase are not processing probabilities. They are processing the fact that their child has a life-threatening disease, that treatment will be long, and that the immediate future will be dominated by hospital wards, lumbar punctures, and the unpredictable side effects of chemotherapy.

The second theme, navigating pediatric crisis as a team, highlights how families reorganize themselves under pressure. Parents described dividing labor between the hospitalized child and the rest of the household, coordinating with partners, grandparents, and siblings, and renegotiating work schedules to keep one parent at the bedside. This division is rarely symmetrical. In many families, one parent, most often the mother, becomes the primary caregiver in the hospital while the other maintains income and cares for siblings at home. The strain of this split, the study suggests, is one of the least visible burdens of the induction phase, because healthcare systems tend to focus on the patient in the bed and the parent in the room, leaving the rest of the family structure to fend for itself. The authors frame this in terms of family-centered care, an approach that treats the family, not just the child, as the unit of care.

Meeting the child’s needs, the third theme, describes the parents’ constant effort to shield their children from fear and pain while keeping them developmentally on track. Parents worried about how to explain procedures in age-appropriate language, how to manage distress during painful interventions, and how to preserve moments of normalcy, play, and routine inside a hospital environment. This concern is well grounded in the pediatric literature: children undergoing cancer treatment report fears related to procedures, separation, and the unfamiliar hospital setting, and parental distress and child distress are known to be tightly linked. A meta-analysis cited by the authors found consistent relationships between parent and child distress in pediatric cancer, meaning that a parent’s ability to stay regulated is not just a private matter but part of the child’s therapeutic environment.

The fourth theme, dealing with uncertainty, may be the most psychologically corrosive of all. Even with favorable prognosis, the induction phase is filled with unknowns: how the child will respond to chemotherapy, whether complications such as infections or mucositis will arise, how long hospitalizations will last, and what daily life will look like afterward. Parents described living in a state of suspended certainty, unable to plan, unable to predict, and constantly recalibrating hope against fear. Research on pediatric medical traumatic stress supports this picture, showing that the diagnosis and early treatment period can trigger posttraumatic stress symptoms in both children and parents. Uncertainty, in this framing, is not a passing emotion but a chronic condition of the treatment trajectory, one that clinical teams can either exacerbate or buffer through clear, honest, and repeated communication.

The fifth theme, guiding parents through ALL, turns the lens on what families say they need from the healthcare system. Parents called for better information, delivered in digestible forms and at the right moments, rather than in overwhelming bursts at admission. They asked for improved communication from doctors and nurses, including consistency in what different team members said and greater attention to parents’ own emotional states. They also pointed to the hospital environment itself, arguing that child-friendly spaces, adequate facilities for parents staying overnight, and attention to the physical comfort of families would meaningfully reduce the burden of long admissions. These are not luxury requests, the authors argue, but structural features of care that shape how families cope with the hardest phase of treatment.

From these five themes, the study draws concrete recommendations. The authors argue that comprehensive, tailored psychosocial interventions should begin at admission, not weeks or months into treatment. Family-centered care and integrated care plans, in which psychological, social, and practical support are coordinated alongside medical treatment, are described as essential for protecting family well-being through the illness trajectory. The recommendation aligns with established standards of psychosocial care in pediatric cancer, which call for routine screening of parental distress and systematic inclusion of psychosocial professionals in oncology teams. It also echoes the authors’ own earlier quantitative work, which found that family functioning and resilience mediate parental psychological adjustment, and that parental distress is linked to children’s health-related quality of life during treatment.

The study’s methodology deserves attention because it shapes what the findings can tell us. Inductive content analysis is well suited to capturing the texture of lived experience, but it relies on self-selected participants and retrospective or concurrent self-report, which means the sample may overrepresent parents who were willing and able to articulate their experiences. The researchers took steps to ensure rigor, including ethical approval from the University of Minho and from the ethics committees of all three participating hospitals, informed consent from all participants, and confidentiality protections for the sensitive survey data. The work was conducted at the Psychology Research Centre of the University of Minho and funded by the Portuguese Foundation for Science and Technology, with the first author supported by a doctoral fellowship. The authors declared no competing interests.

What makes this study resonate beyond Portugal is the universality of its core insight: the induction phase of childhood leukemia treatment is a family emergency, not merely a pediatric one. Survival statistics tell us that most children diagnosed with acute lymphoblastic leukemia today will be cured, but the parents in this study remind us that cure is achieved through months of exhausting, fear-laden, uncertain caregiving that leaves lasting marks on families. If hospitals invest in communication, in child-friendly environments, and in psychosocial support that starts on day one, the authors conclude, they can change not the biology of the disease but the experience of surviving it, for children and for the parents who carry them through it.

Subject of Research: Parental and family experiences during the induction phase of childhood acute lymphoblastic leukemia treatment

Article Title: Family Experiences Through Childhood Acute Lymphoblastic Leukemia: A Qualitative Study on Challenges and Needs During the Initial Intensive Treatment Phase

Article References: Ferraz, A., Santos, M., Jerónimo, M., & Pereira, M. G. (2026). Family Experiences Through Childhood Acute Lymphoblastic Leukemia: A Qualitative Study on Challenges and Needs During the Initial Intensive Treatment Phase. Journal of Child and Family Studies. https://doi.org/10.1007/s10826-026-03379-x

Image Credits: AI Generated

DOI: 10.1007/s10826-026-03379-x

Keywords: acute lymphoblastic leukemia, pediatric oncology, induction phase, parental distress, family-centered care, qualitative research, psychosocial interventions, hospitalization, childhood cancer, uncertainty, communication in healthcare, family functioning